Healthcare Europa

The only information source for private healthcare services in Europe, click here to download a brochure

Mid Europa enters the Serbian private healthcare market

Private equity investor Mid Europa has entered the Serbian private healthcare market for the first time, with the acquisition of hospital operator MediGroup. We speak to a partner at seller Blue Sea Capital.

Turkey’s largest hospital group on the hunt for acquisitions

MLP Care, Turkey's largest hospital group which runs the Medical Park chain, saw substantial revenue and  EBITDA growth in the first six months of the year. Group CFO Burcu Ozturk tells us that is now looking to expand via acquisitions after opening two new hospitals this year.

“No interest” in BMI, propco takeover increasingly likely, say sources

We hear that South African hospital group Netcare has received a less-than-lukewarm reception so far when trying to market its UK asset BMI Healthcare this summer and that a takeover by the propco owners is the most likely scenario, as we reported earlier. But how will the incoming owner return the business to profitability? One well-placed […]

Why investors are viewing the UK market with caution

Is the UK is losing out to Europe when it comes to healthcare deals? With so much for sale and so little buying activity recently, Healthcare Europa catches up with a UK market analyst to find out more.

Interview: Philip Buergin, CEO, Colosseum Dental UK

Healthcare Europa talks to Philip Buergin, the new CEO of Jacobs Holding-backed Colosseum Dental UK, about problems and opportunities in the UK dental market, the wider European perspective, and Colosseum's plans for the future.

Falck defines core entities and puts Danish clinics into strategic review

Falck, the world's largest emergency services group which had 10.88bn Dkr (€1.45bn) of revenue from ambulances and health services, has defined its core businesses. Two businesses are "undergoing strategic reviews". There are rumours that majority shareholder, Lundbeck Foundation, might sell off the entire group.

Infermedica CEO on why AI specialists should prefer B2B over B2C

As doctors and nurses are an increasingly scarce and expensive resource, companies across Europe are turning to artificial intelligence to give patients a pathway into primary health. But is the best business model B2B or B2C? Healthcare Europa speaks to Piotr Orzechowski, CEO of the Poland-based AI specialists Infermedica, about why he sees the future of his business as very much the former, and his strategy for the company.